Alnylam Pharmaceuticals · 4 months ago
Vice President, US Strategic Accounts
United States
Full-time
Hybrid
Director/Executive
15+ years expAlnylam Pharmaceuticals is a leader in translating RNA interference into innovative medicines. The Vice President of US Strategic Accounts will shape the account strategy across organized customers, leading a national team while building partnerships and driving enterprise growth.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Lead the US strategic account team, encompassing health systems, Integrated Delivery Networks (IDNs), and Integrated Provider Networks (IPNs), and other organized provider networks
Lead and coach a high-performing team of Strategic Account Leads responsible for key customer relationships and integrated account plan pull-through execution
Partner closely with US Leadership spanning Market Access, Sales, Marketing, Medical Affairs, Legal, and Compliance to ensure strategic alignment and cross-functional collaboration
Continuously evaluate and refine integrated account plans to ensure sustained access, integration, and utilization of current and future products within target accounts
Prepare the organization and accounts for future US product launches, ensuring proactive engagement and infrastructure readiness
Serve as the internal “voice of the customer” and integrate it into strategic planning and brand development processes
Identify and shape innovative, compliant solutions that address the evolving needs of complex US healthcare providers
Develop and monitor key performance indicators (KPIs) to assess account-level performance and adjust strategies based on insights and feedback
Represent Strategic Accounts at internal leadership meetings and with external stakeholders to drive visibility, alignment, and impact
Qualification
Required
Bachelor's degree required; MBA or advanced scientific degree (e.g., M.D., Ph.D., PharmD) strongly preferred
15+ years of progressive US focused commercial experience in the pharmaceutical/biotechnology industry, including at least 8 years in strategic or key account leadership roles and prior second-line management responsibility
Proven success in leading commercial launches and account strategy development with deep expertise in the US healthcare ecosystem. Particularly health systems, Integrated Delivery Networks (IDNs), and Integrated Provider Networks (IPNs), and other organized provider networks
Strong leadership capabilities with a demonstrated ability to hire, develop, and manage high-performing, field-based teams, while driving a culture of accountability and performance
Skilled at working within cross-functional, matrixed environments, with a proven ability to collaborate and influence across Sales, Marketing, Market Access, Medical Affairs, Legal, and Compliance teams
Demonstrated leadership within network-based operating models, with the ability to influence senior stakeholders, navigate ambiguity, and drive alignment in a fast-paced, growth-oriented organization
Excellent executive presence, communication skills, and a strong commitment to ethics and integrity; must be comfortable with up to 50% travel and regular in-office presence in Cambridge, MA
In-depth knowledge of the legal and regulatory environment governing the biotech and pharmaceutical sectors
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
Clinical Trials Arena
2026-01-16
Longevity.Technology
2026-01-14
2026-01-13
Company data provided by crunchbase